Skip to main content
. 2020 Aug 17;13(11):100848. doi: 10.1016/j.tranon.2020.100848

Table 3.

Characteristics of mutation status in patients with GIST (n = 32).

No. Amplification
Mutation status
1st PCR Nested PCR Gene Exon Codonb, c Type
1 Failure None
2 KIT 11 V559D PM
3 KIT 9 503AY504 I
4 KIT 13 K642E PM
5 PDGFRA 18 D842V PM
6 KIT 11 550–558 D
7 KIT 11 555 D
8 KIT 11 W557R PM
9 KIT 11 579DPTQLPYD580 I
10 KIT 11 W557R PM
11 PDGFRA 18 D842V PM
12 KIT 11 580DH581 I
13 KIT 11 V560E PM
14 KIT 11 573DP574 I
15 KIT 11 585YDHKWEFP586 I
16 KIT 11 V560D PM
17 KIT 11 L577P PM
18 KIT 11 V561D PM
19 KIT 11 L577P PM
20 KIT 11 V560D PM
21 KIT 11 L576P PM
22 KIT 11 561–562 D
23 Failure KIT 11 560 D
24 KIT 11 V559D PM
25 KIT 11 558 D
26 KIT 11 580DPTQLPYDH581 I
27 KIT 11 560 D
28 Failure None
29a Failure Failure None
30 KIT 11 V559D PM
31 KIT 11 585LPYDHKWEFP586 I
32 KIT 11 557–558 D
a

Mutation status of No.29 was analyzed using surgical tissue sample because of failure to amplification by FNA sample.

b

Each letter indicates the amino acid that was inserted or substituted due to the gene mutation (e.g., V559D indicates that valine was substituted for aspartic acid at codon 559 due to a point mutation, and 503AY504 indicates that alanine and tyrosine were inserted between codons 503 and 504).

c

The numbers in the codon column indicate deleted codons (e.g., 557–558 indicates that codons 557 and 558 were deleted).

Abbreviations. D, deletion; PM, point mutation; I, insertion.